Search

everythinglearnresearchcommunity

for

Search:↓

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Dihydroxyacetone in self-tanning lotion helped reduce sun-related skin issues in a woman with variegate porphyria.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

ZD1839 can cause skin issues like acne and hair changes.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Certain medications can cause serious side effects, so it's important to report them.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Methotrexate plus prednisolone had the fewest serious side effects.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Retinoic acid affects skin and hair health by working with specific receptors, and its absence can lead to hair loss and skin changes.

Upadacitinib may cause hair loss.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

CS12192 effectively treats alopecia areata with better safety than current options.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.